Dr. Yeycy Donastorg Cabral
Medical Doctor, Master in Public Health and in Population Studies, and Researcher. With experience in sexual and reproductive health programs, in the field of educational health communication, research ethics and conducting clinical, sociodemographic and applied research.
For the last 21 years she has coordinated the Vaccines and Research Unit at the Dermatological Institute, from which she has conducted studies of vaccines against HIV, chikungunya and COVID 19, as well as studies of antiretroviral drugs and applied research for the development of models of intervention to improve the lives of people living with HIV. She is currently the principal investigator of the pediatric clinical trials of the COVID 19 vaccines of Novavax and Moderna and the pediatric vaccine against Chikungunya of Valneva and Co-investigator of the NCI Opportunity study-EVITA-ULACNET Collaboration.